The Department for Business, Energy and Industrial Strategy is consulting until 17 April on a document setting out the government’s new collaborative approach to industrial strategy.
The Department for Business, Energy and Industrial Strategy is consulting until 17 April on a document setting out the government’s new collaborative approach to industrial strategy. The objective of the strategy is to improve living standards and economic growth by increasing productivity and driving growth across the UK.
The consultation document, Building our industrial strategy (see http://bit.ly/2iVIGyl), sets out 10 ‘pillars’ for this strategy:
A key aspect will be the review of the tax environment for research and development, announced at the Autumn Statement. The document references studies showing a correlation between government investment and tax support for R&D, and the amount that private businesses invest. The document notes the government’s pledge to provide an additional £4.7bn of funding for R&D by 2020/21.
Another important element of the strategy involves the availability of long-term funding. The Treasury has published the terms of reference for its review of ‘patient capital’ for growing businesses, which will consider all aspects of the financial system affecting the provision of long-term finance to growing innovative firms. In particular, the review will:
The patient capital review will publish a consultation in spring 2017. See http://bit.ly/2jP6n91.
The Department for Business, Energy and Industrial Strategy is consulting until 17 April on a document setting out the government’s new collaborative approach to industrial strategy.
The Department for Business, Energy and Industrial Strategy is consulting until 17 April on a document setting out the government’s new collaborative approach to industrial strategy. The objective of the strategy is to improve living standards and economic growth by increasing productivity and driving growth across the UK.
The consultation document, Building our industrial strategy (see http://bit.ly/2iVIGyl), sets out 10 ‘pillars’ for this strategy:
A key aspect will be the review of the tax environment for research and development, announced at the Autumn Statement. The document references studies showing a correlation between government investment and tax support for R&D, and the amount that private businesses invest. The document notes the government’s pledge to provide an additional £4.7bn of funding for R&D by 2020/21.
Another important element of the strategy involves the availability of long-term funding. The Treasury has published the terms of reference for its review of ‘patient capital’ for growing businesses, which will consider all aspects of the financial system affecting the provision of long-term finance to growing innovative firms. In particular, the review will:
The patient capital review will publish a consultation in spring 2017. See http://bit.ly/2jP6n91.